Holen Sie sich die Stockscreener-App
0.973
0.83%
0.008
Handel nachbörslich:
.97
-0.003
-0.31%
Schlusskurs vom Vortag:
$0.965
Offen:
$0.98
24-Stunden-Volumen:
273.83K
Relative Volume:
0.40
Marktkapitalisierung:
$96.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.65M
KGV:
-2.9298
EPS:
-0.3321
Netto-Cashflow:
$-15.84M
1W Leistung:
-4.61%
1M Leistung:
-19.59%
6M Leistung:
-8.21%
1J Leistung:
-38.42%
1-Tages-Spanne:
$0.94
$0.9979
1-Wochen-Bereich:
$0.94
$1.05
52-Wochen-Spanne:
$0.7709
$1.67
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Vergleichen Sie CRDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
0.973 | 96.50M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy |
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Is Cardiol Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
What is the fair value of Cardiol Therapeutics Inc. stock now2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changesWeekly Trend Report & Technical Entry and Exit Tips - newser.com
How Cardiol Therapeutics Inc. stock performs during Fed tightening cyclesTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industry2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued after correctionJuly 2025 Setups & Detailed Earnings Play Alerts - newser.com
Is Cardiol Therapeutics Inc. stock poised for growthQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualized2025 Market WrapUp & Growth Focused Stock Reports - newser.com
How buyback programs support Cardiol Therapeutics Inc. (CT9) stockProfit Target & Free High Return Stock Watch Alerts - newser.com
Cardiol Therapeutics Inc. stock chart pattern explainedJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued at current priceWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly dataWeekly Trend Recap & High Conviction Buy Zone Picks - newser.com
How to build a custom watchlist for Cardiol Therapeutics Inc.Earnings Summary Report & Weekly High Potential Alerts - newser.com
Technical analysis overview for Cardiol Therapeutics Inc. stockJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Cardiol Therapeutics wins US patent protection for heart-disease drug platform - Indian Pharma Post
How Cardiol Therapeutics Inc. stock benefits from tech adoptionQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stockTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Where are the Opportunities in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):